Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
Cash Flows From Operating Activities | |||||
Net Income | 3,629 | 6,035 | 4,604 | 5,893 | 11,190 |
Depreciation Amortization | 1,435 | 819 | 384 | 460 | 710 |
Income taxes - deferred | 377 | 697 | 660 | 1,911 | -11,181 |
Accounts receivable | 378 | -2,287 | -1,443 | 287 | -933 |
Accounts payable and accrued liabilities | -130 | 1,133 | -313 | 487 | 442 |
Other Working Capital | -3,360 | -3,488 | -4,465 | -2,942 | 22,493 |
Other Operating Activity | 1,078 | 1,583 | 2,574 | 356 | 1,103 |
Operating Cash Flow | $3,407 | $4,493 | $2,001 | $6,452 | $23,825 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 3,500 | -3,527 | N/A | N/A | 818 |
PPE Investments | -16,247 | -13,756 | -1,306 | -1,601 | -474 |
Purchase Sale Intangibles | N/A | -1,000 | N/A | N/A | N/A |
Other Investing Activity | -58 | -1,000 | 0 | 0 | 0 |
Investing Cash Flow | $-12,805 | $-18,283 | $-1,306 | $-1,601 | $344 |
Cash Flows From Financing Activities | |||||
Debt Issued | 16,000 | N/A | N/A | N/A | N/A |
Common Stock Issued | 517 | 1,883 | 1,220 | 556 | 578 |
Other Financing Activity | 170 | 643 | 506 | 0 | 0 |
Financing Cash Flow | $16,687 | $2,526 | $1,725 | $556 | $578 |
Beginning Cash Position | 35,904 | 47,167 | 44,747 | 39,339 | 14,592 |
End Cash Position | 43,194 | 35,904 | 47,167 | 44,747 | 39,339 |
Net Cash Flow | $7,290 | $-11,264 | $2,421 | $5,407 | $24,747 |
Free Cash Flow | |||||
Operating Cash Flow | 3,407 | 4,493 | 2,001 | 6,452 | 23,825 |
Capital Expenditure | -16,247 | -13,756 | -1,306 | -1,601 | -474 |
Free Cash Flow | -12,839 | -9,263 | 695 | 4,851 | 23,351 |